Observational study on pregnancy and child health in Shenyang, China
Birth Cohort Study of China Medical University in Shenyang
This study looks at how different factors affect the health of pregnant women and their children in Shenyang, China, by collecting information and samples from them over 18 years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Shengjing Hospital Academic / other |
| Locations | 1 site (Shenyang, Liaoning) |
| Trial ID | NCT03561766 on ClinicalTrials.gov |
What this trial studies
The CMUBCS is an observational birth cohort study aimed at understanding how genetic and environmental factors influence health outcomes in pregnant women and their children. It collects comprehensive data on lifestyle, clinical outcomes, and imaging results from pregnant women and their children from birth to 18 years old. Biological samples, including blood and tissue, are also gathered to facilitate long-term health assessments. The study focuses on various complications during pregnancy, including advanced maternal age and obesity, to identify predictors of health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women who are less than 13 weeks gestational age and are permanent residents of Shenyang.
Not a fit: Patients with neuropsychiatric disorders or those who refuse to participate in the study may not benefit from this research.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into preventing chronic diseases in children and improving maternal health.
How similar studies have performed: Other studies have shown success in understanding the impact of early life factors on health outcomes, making this approach both relevant and promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Pregnant women, \<13 gestational weeks 2. Permanent residents or families intended to remain in Shenyang and surrounding areas 3. Pregnant women who are planned to be examined and delivered in Shengjing Hospital. Exclusion Criteria: 1. Pregnant women who refuse to take part in the study 2. Pregnant women have diseases that might affect the results of researches, including neuropsychiatric disorders.
Where this trial is running
Shenyang, Liaoning
- Shengjing Hospital — Shenyang, Liaoning, China (Recruiting)
Study contacts
- Principal investigator: Caixia Liu — Shengjing Hospital
- Study coordinator: Caixia Liu
- Email: liucx1716@163.com
- Phone: 86-18902451716
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.